Back to search

National and Kapodistrian University of Athens

Ο ρόλος της περιοστίνης στο βρογχικό άσθμα και στη χρόνια αποφρακτική πνευμονοπάθεια

Abstract

dc:description

Serum Periostin in patients hospitalized for COPD exacerbations Background: Serum periostin has been proposed as a surrogate biomarker of Th2 inflammatory response in patients with asthma, but its predictive role in hospitalized patients with COPD has not been evaluated. Objective: The aim of the present observational prospective cohort study was to evaluate the possible role of serum periostin as predictor of outcome in COPD patients hospitalized for AECOPD. Methods: Serum periostin was measured on admission and at discharge in patients admitted to the hospital for a COPD exacerbation. Patients were followed-up for 1year for future exacerbations, hospitalizations and mortality. Results: 155 consecutive patients admitted to the hospital for AECOPD were included to the study. Periostin levels on admission were elevated compared to discharge [34.7 (25.2-52.2) vs. 25.9 (17.4-41.0) ng/mL, p=0.003], but serum periostin levels did not differ between patients with or without prolonged hospitalization, or those who required non-invasive ventilation, intubation, or died during hospitalization. Frequent exacerbators had higher serum periostin levels at the time of discharge compared to non-frequent exacerbators [37.9 (26.6, 64.5) vs. 23.9 (16.2, 37.9), p<0.001]. Periostin levels above the median value (25ng/mL) were not related to the time of next exacerbation, time of next COPD hospitalization, (p=0.858) or time to death. Conclusion: The role of serum periostin levels as a predictive biomarker of future risk in hospitalized patients with COPD is of limited value.The association between serum periostin and a type 2 helper airway composite index in optimally treated asthmatics Background: Serum periostin is an extracellular matrix protein secreted by bronchial epithelial cells and lung fibroblasts and serves as a basic component of subepithelial fibrosis observed in the asthmatic airways. Its expression is upregulated by type 2 cytokines IL-4 and IL-13, and it has been recognized as a surrogate marker of Th2 response. Recent data support an association between serum periostin with a type 2 immunity score consisting of blood eosinophils, sputum eosinophils, fraction of exhaled nitric oxide (FeNO) and IgE.Objective: The aim of this prospective study was the evaluation of the diagnostic performance of serum periostin in the assessment of a type 2 airway composite index in optimally treated asthmatics and the potential role of the underlying disease severity. Moreover we evaluated the association of periostin with various inflammatory study variables.Methods: All patients underwent dynamic spirometry and sputum induction. Sputum cell counts and measurement of IL-13 in sputum supernatant were performed. Blood was drawn for the measurement of periostin and blood eosinophils. A composite Th2 airway index was determined by using the following variables: sputum eosinophils ≥ 3%, FeNO ≥25 ppb and sputum IL-13 ≥ 66 pg/mL.Results: In total 145 patients were recruited (56 with SRA and 89 with mild-to-moderate asthma), nonsmokers, all optimally treated forat least 6 months. Inflammatory variables were elevated in patients with severe asthma compared with those with mild to moderate. In the whole population, periostin showed a weak predictive performance in the assessment of the Th2 composite index. Periostin also failed to predict the Th2 index in patients with SRA, however, in patients with mild-to-moderate asthma, periostin showed a weak performance for the identification of a high airway Th2 composite score. Periostin failed to show a statistically significant performance for all the individual components of the composite index. Regression analysis evaluating the associations of serum periostin with inflammatory markers revealed that the only significant association was with both the absolute count and the percentage of blood eosinophils (B coefficient 3.76, P < .001, and B coefficient 5.13, P < .045, respectively).Conclusion: Serum periostin is a poor predictor of Th2 airway response, raising questions regarding its potential role in treatment stratification strategies.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Konstantelou, Elissavet
  • Κωνσταντέλου, Ελισσάβετ

Subjects

dc:subject × 6

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42762

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Konstantelou, Elissavet; Κωνσταντέλου, Ελισσάβετ. Ο ρόλος της περιοστίνης στο βρογχικό άσθμα και στη χρόνια αποφρακτική πνευμονοπάθεια. National and Kapodistrian University of Athens, 2018. http://hdl.handle.net/10442/hedi/42762